IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Condition:   Metastatic Uveal Melanoma Interventions:   Drug: IDE196;   Drug: Crizotinib;   Drug: Pembrolizumab;   Drug: Ipilimumab;   Drug: Nivolumab;   Drug: Dacarbazine Sponsor:   IDEAYA Biosciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials